The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors
Open accessAbstract
BACKGROUND: The immune system plays an important role in cancer surveillance and therapy. Chemoradiation can cause severe treatment-related lymphopenia (TRL) (<500 cells/mm3) that is associated with reduced survival. MATERIALS AND METHODS: Data from 4 independent solid tumor studies on serial lymphocyte counts, prognostic factors, treatment, and survival were collected and analyzed. The data set included 297 patients with newly diagnosed malignant glioma (N=96), resected pancreatic cancer (N=53), unresectable pancreatic cancer (N=101), and non-small cell lung cancer (N=47). RESULTS: Pretreatment lymphocyte counts were normal in 83% of the patient population, and no patient had severe baseline lymphopenia. Two months after initiating chemoradiation, 43% developed severe and persistent lymphopenia (P=.001). An increased risk for death was attributable to TRL in each cancer cohort (gliomas: hazard rate [HR], 1.8; 95% CI, 1.13-2.87; resected pancreas: HR, 2.2; 95% CI, 1.17-4.12; unresected pancreas: HR, 2.9; 95% CI, 1.53-5.42; and lung: HR, 1.7; 95% CI, 0.8-3.61) and in the entire study population regardless of pathologic findings (HR, 2.1; 95% CI, 1.54-2.78; P<.0001). Severe TRL was observed in more than 40% of patients 2 months after initiating chemoradiation, regardless of histology or chemotherapy regimen, and was independently associated with shorter survival from tumor progression. CONCLUSIONS: Increased attention and research should be focused on the cause, prevention, and reversal of this unintended consequence of cancer treatment that seems to be related to survival in patients with solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Journal of the American Statistical Association
Koehler, A. B. (1995) · International Journal of Forecasting · doi:10.1016/0169-2070(95)90067-5 · Cited by 5,337
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0902 · Cited by 1,632
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Gooden, M. J. M., de Bock, G. H., Leffers, N., Daemen, T., & Nijman, H. W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.189 · Cited by 1,277
A Confidence Interval for the Median Survival Time
Brookmeyer, R., & Crowley, J. (1982) · Biometrics · doi:10.2307/2530286 · Cited by 914
Ray-Coquard, I., Cropet, C., Van Glabbeke, M., Sebban, C., Le Cesne, A., Judson, I., Tredan, O., Verweij, J., Biron, P., Labidi, I., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3845 · Cited by 784
Neyeloff, J. L., Fuchs, S. C., & Moreira, L. B. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-52 · Cited by 727
Cancer Immunotherapy Comes of Age
Topalian, S. L., Weiner, G. J., & Pardoll, D. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0899 · Cited by 586
Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
Grossman, S. A., Ye, X., Lesser, G., Sloan, A., Carraway, H., Desideri, S., & Piantadosi, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0774 · Cited by 578
Self-citationThe anticancer immune response: indispensable for therapeutic success?
Zitvogel, L., Apetoh, L., Ghiringhelli, F., André, F., Tesniere, A., & Kroemer, G. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35180 · Cited by 573
Grossman, S. A., Ye, X., Piantadosi, S., Desideri, S., Nabors, L. B., Rosenfeld, M., Fisher, J., & for the NABTT CNS Consortium (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3106 · Cited by 448
Self-citationYovino, S., Kleinberg, L., Grossman, S. A., Narayanan, M., & Ford, E. (2013) · Cancer Investigation · doi:10.3109/07357907.2012.762780 · Cited by 417
Self-citationBremnes, R. M., Al-Shibli, K., Donnem, T., Sirera, R., Al-Saad, S., Andersen, S., Stenvold, H., Camps, C., & Busund, L.-T. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182037b76 · Cited by 369
Mei, Z., Liu, Y., Liu, C., Cui, A., Liang, Z., Wang, G., Peng, H., Cui, L., & Li, C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.46 · Cited by 305
Fuks, Z., Strober, S., Bobrove, A. M., Sasazuki, T., McMichael, A., & Kaplan, H. S. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108532 · Cited by 273
Treatment-related Lymphopenia in Patients With Stage III Non-Small-Cell Lung Cancer
Campian, J. L., Ye, X., Brock, M., & Grossman, S. A. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.767342 · Cited by 233
Self-citationWild, A. T., Ye, X., Ellsworth, S. G., Smith, J. A., Narang, A. K., Garg, T., Campian, J., Laheru, D. A., Zheng, L., Wolfgang, C. L., et al. (2015) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182940ff9 · Cited by 211
Self-citationBalmanoukian, A. S., Ye, X., Herman, J. M., Laheru, D. A., & Grossman, S. A. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.700987 · Cited by 160
Self-citationEnhancement of T cell recruitment and infiltration into tumours
Oelkrug, C., & Ramage, J. M. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12382 · Cited by 153
Radiation-Induced Lymphocyte-Immune Deficiency
Meyer, K. K. (1970) · Archives of Surgery · doi:10.1001/archsurg.1970.01340260018003 · Cited by 146
Ellsworth, S. G., & Grossman, S. A. (2012) · CNS Oncology · doi:10.2217/cns.12.14 · Cited by 108
Self-citationChildhood, M. R. C. W. P. O. L. I., MacLennan, I. C. M., & Kay, H. E. M. (1978) · Cancer · doi:10.1002/1097-0142(197801)41:1<108::aid-cncr2820410116>3.0.co;2-z · Cited by 94
Ellsworth, S. G., Balmanoukian, A. S., Kos, F. J., Nirschl, C. J., Nirschl, T. R., Grossman, S. A., Luznik, L., & Drake, C. G. (2014) · OncoImmunology · doi:10.4161/onci.27357 · Cited by 89
Self-citationGrulich, A. E. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328329c5b2 · Cited by 26
Cited by
Brain immunology and immunotherapy in brain tumours
Sampson, J. H., Gunn, M. D., Fecci, P. E., & Ashley, D. M. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0224-7 · Cited by 722
Liau, L. M., Ashkan, K., Tran, D. D., Campian, J. L., Trusheim, J. E., Cobbs, C. S., Heth, J. A., Salacz, M., Taylor, S., D’Andre, S. D., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1507-6 · Cited by 537
Self-citationRadiotherapy: Changing the Game in Immunotherapy
Demaria, S., Coleman, C. N., & Formenti, S. C. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.05.002 · Cited by 363
Metadata
- Authors
- Grossman, S. A., Ellsworth, S., Campian, J., Wild, A. T., Herman, J. M., Laheru, D., Brock, M., Balmanoukian, A., & Ye, X.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2015-10
- Volume
- 13
- Issue
- 10
- Pages
- 1225-1231
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W1757492577
- Cited by
- 310
- References
- 31
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.